| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.29 | 0.06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.11 | 0.06 |